Home/ Supplements/ Electrolytes/ Oyster Shell Calcium 500 mg

Oyster Shell Calcium 500 mg

product on market Tablet or Pill Major Pharmaceuticals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Oyster Shell Calcium 500 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Mineral
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
500 mg (50% DV)

Other Ingredients

Microcrystalline Cellulose Acacia Maltodextrin Croscarmellose Sodium Hypromellose Titanium Dioxide Soy Polysaccharides Sodium Lauryl Sulfate Talc Triacetin Stearic Acid Mineral Oil Riboflavin FD&C Blue No. 1 Lake
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: For adults, take one (1) tablet daily as a dietary supplement preferably with a meal.

Warnings & Precautions

Contains: Soy and shellfish (oyster) ingredients.

Keep this and all medication out of the reach of children.

Do not use if blister unit is broken

Calcium and other minerals can affect the absorption of many medications. Do not take this product within 2 hours of taking medications. As a reminder, discuss the supplements and medications you take with your health care providers and follow their advice. Warning: Pregnant or lactating women should consult a doctor before using any product.

Avoid this product if you have allergies to shellfish or a history of kidney stones.

Consult your doctor before use if you have, or had any health condition or if you are taking any medications or remedies, including OTC medications, or are planning any medical procedure.

Discontinue use and consult your doctor if any adverse reactions occur, such as gastrointestinal discomfort.

Not intended for use by persons under the age of 18.

Formulation Notes

Oyster Shell Calcium (Elemental) Supplement Contains: Soy and shellfish (oyster) ingredients.

Additional Information

Unit Dose

Store at 20(0)-25(0)C (68(0)-77(0)F); excursions permitted to 15(0)-30(0)C (59(0)-86(0)F). [See USP Controlled Room Temperature]

Re-Order No. 301827 M-29 Rev. 06/17 10196-06-17

Metadata

Product Details

UPC / SKU3 09041 88361 1
DSLD Entry Date2019-04-25
Product TypeMineral
FormTablet or Pill
DSLD ID201733
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.